Suppr超能文献

产超广谱β-内酰胺酶(ESBL)肠杆菌科细菌引起感染的患病率及危险因素

Prevalence and risk factors of infections caused by extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae.

作者信息

Nakai Hazuki, Hagihara Mao, Kato Hideo, Hirai Jun, Nishiyama Naoya, Koizumi Yusuke, Sakanashi Daisuke, Suematsu Hiroyuki, Yamagishi Yuka, Mikamo Hiroshige

机构信息

Department of Clinical Infectious Diseases, Aichi Medical University Graduate School of Medicine, Japan.

Department of Infection Control and Prevention, Aichi Medical University Hospital, Japan; Department of Pharmacy, Aichi Medical University Hospital, Japan.

出版信息

J Infect Chemother. 2016 May;22(5):319-26. doi: 10.1016/j.jiac.2016.02.004. Epub 2016 Mar 8.

Abstract

OBJECTIVE

To study the clinical characteristics and associated risk factors of infections caused by extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae.

METHODS

A case-control study at a large university hospital in Japan, comparing patients who were infected or colonized with ESBL-producing Enterobacteriaceae (n = 212) and non-ESBL-producing Enterobacteriaceae (n = 2089) in 2010-2013. Data were collected from medical charts, retrospectively. Multivariate logistic regression analysis was used to explore risk factors of ESBL-producing Enterobacteriaceae (Escherichia coli, Klebsiella pneumoniae, Klebsiella oxytoca, Proteus mirabilis) infection or colonization for each pathogen, respectively.

RESULTS

ESBL-producing Enterobacteriaceae [E. coli (n = 113), K. oxytoca (n = 46), K. pneumoniae (n = 41), P. mirabilis (n = 12)] were taken from patients were identified in 1409 outpatient and 892 inpatients. Infection or colonization caused by ESBL-producing Enterobacteriaceae was considered to be hospital-acquired, healthcare-associated and community-acquired in 60.4%, 17.9% and 21.7% patients, respectively. Independent risk factors for ESBL-producing Enterobacteriaceae infection or colonization were male sex, cerebrovascular disease, intubation/tracheostomy, major surgery within 60 days (p < 0.001). Moreover, antimicrobial usage (more than 4 days) during preceding 60 days, especially aminoglycoside, oxazolidinone, tetracycline, fluoroquinolone, trimethoprim/sulfamethoxazole, and second- and fourth-generation cephalosporin were risk factors (p < 0.001). However, acquisition location of infection (hospital-acquired and community-onset) was not a risk factor (p > 0.05).

CONCLUSION

The problem of ESBL production is no longer limited to hospital-acquired infections. The presence of chronic illness, such as cerebrovascular disease, and recent antimicrobial use were independent risk factors for ESBL-producing Enterobacteriaceae infection or colonization.

摘要

目的

研究产超广谱β-内酰胺酶(ESBL)肠杆菌科细菌感染的临床特征及相关危险因素。

方法

在日本一家大型大学医院进行病例对照研究,比较2010 - 2013年期间感染或定植产ESBL肠杆菌科细菌(n = 212)和非产ESBL肠杆菌科细菌(n = 2089)的患者。数据通过回顾性收集病历获得。采用多因素logistic回归分析分别探讨每种病原体(大肠埃希菌、肺炎克雷伯菌、产酸克雷伯菌、奇异变形杆菌)感染或定植产ESBL肠杆菌科细菌的危险因素。

结果

产ESBL肠杆菌科细菌[大肠埃希菌(n = 113)、产酸克雷伯菌(n = 46)、肺炎克雷伯菌(n = 41)、奇异变形杆菌(n = 12)]分离自1409例门诊患者和892例住院患者。产ESBL肠杆菌科细菌引起的感染或定植分别在60.4%、17.9%和21.7%的患者中被认为是医院获得性、医疗保健相关和社区获得性的。产ESBL肠杆菌科细菌感染或定植的独立危险因素为男性、脑血管疾病、插管/气管切开术、60天内的大手术(p < 0.001)。此外,前60天内使用抗菌药物(超过4天),尤其是氨基糖苷类、恶唑烷酮类、四环素类、氟喹诺酮类、甲氧苄啶/磺胺甲恶唑以及第二代和第四代头孢菌素是危险因素(p < 0.001)。然而,感染的获得部位(医院获得性和社区起病)不是危险因素(p > 0.05)。

结论

产ESBL问题不再局限于医院获得性感染。慢性疾病(如脑血管疾病)的存在以及近期使用抗菌药物是产ESBL肠杆菌科细菌感染或定植的独立危险因素。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验